Gavin Clark-Gartner
Stock Analyst at Evercore ISI Group
(0)
# 4819
Out of 5,372 analysts
29
Total ratings
28.00%
Success rate
-19.47%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
PRQR ProQR Therapeutics | Initiates Coverage On: Outperform | 5 | 1.89 | 164.55% | 1 | Apr 29, 2025 | |
ABBV AbbVie | Maintains: Outperform | 204 205 | 185.53 | 10.49% | 3 | Apr 28, 2025 | |
MNMD Mind Medicine | Initiates Coverage On: Outperform | 23 | 6.71 | 242.77% | 1 | Jan 28, 2025 | |
CABA Cabaletta Bio | Downgrades: In-Line | 15 6 | 1.86 | 222.58% | 2 | Dec 20, 2024 | |
ARGX argenx | Maintains: Outperform | 675 706 | 540.53 | 30.61% | 4 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 179 170 | 21.59 | 687.4% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 65 65 | 5.46 | 1090.48% | 2 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 4.8 | 316.67% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 201 206 | 130.19 | 58.23% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 66 | 50.69 | 30.2% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 22 | 1.41 | 1460.28% | 1 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 10 | 1.49 | 571.14% | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 54 60 | 14.62 | 310.4% | 1 | Oct 5, 2022 |